Testing cognitive behavioral therapy components for fatigue in multiple sclerosis
Official title: Factorial Optimization Randomized Controlled Trial to Test The Effects of Cognitive Behavioral Therapy Components For Multiple Sclerosis Fatigue
Run by University of Washington · NCT06809192 · Data updated 2026-11-12
This study is testing whether different types of therapy can help adults with multiple sclerosis feel less tired and improve their daily functioning.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 112 (estimated) |
| Sponsor | University of Washington Academic / other |
| Locations | 1 site (Seattle, Washington) |
| Status | Recruiting |
| Started | January 10, 2025 |
| Main results expected | December 31, 2026 |
| Study ends | March 31, 2027 |
| Registry record updated | March 16, 2026 |
| Trial ID | NCT06809192 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older with a confirmed diagnosis of multiple sclerosis and significant fatigue as measured by the Fatigue Severity Scale.
✕Probably not a fit
Patients who have experienced a recent MS relapse or have made changes to their disease-modifying medications may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized controlled factorial trial aims to evaluate the effectiveness of relaxation training, behavioral activation, and cognitive therapy in reducing fatigue and improving functioning in adults with multiple sclerosis. Fatigue is a prevalent and debilitating symptom for many individuals with MS, and this study seeks to optimize cognitive behavioral therapy (CBT) components to enhance accessibility and effectiveness. Participants will engage in telehealth sessions focusing on these therapeutic components, which are designed to address the cognitive, emotional, and behavioral aspects of fatigue. The trial employs a balanced factorial design to assess the main and interactive effects of these interventions.
Why it matters
Potential benefit: If successful, this study could provide a more effective and accessible treatment option for managing fatigue in patients with multiple sclerosis.
How similar studies have gone: Other studies have shown promise in using cognitive behavioral therapy for managing fatigue in chronic conditions, suggesting potential success for this approach in multiple sclerosis.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Confirmed MS diagnosis of any subtype 2. Score of 4 or higher on the Fatigue Severity Scale 3. Able to fluently converse and read in English 4. 18 years of age or older 5. Able to comply with study procedures and complete self-report measures 6. Willing to have intervention sessions audiotaped for fidelity coding 7. Has experienced fatigue for 3 or more months Exclusion Criteria: 1. MS relapse within last 30 days (although participants will be considered eligible after the 30-day window) 2. Change in disease modifying medications (DMTs) in the prior three months (although participants will be considered eligible after the 3-month window) 3. Current suicidal ideation with intent or plan as indicated by a score of ≥1 on the Patient Health Questionnaire-9 suicide item and further assessment via the Columbia Suicide Severity Rating Scale (although individuals with suicidal ideation but no intent or plan will be considered eligible) 4. Currently engaged in psychotherapy for fatigue 5. Currently participating in another research study that could impact fatigue such as intervention studies targeting mood, energy management, exercise/physical activity, and diet (although participants can be screened for eligibility again once they have completed the other research study)
Where it's running
-
Multiple Sclerosis Center at UW Medical Center - Northwest
Seattle, Washington, United States Recruiting
Study contacts
- Principal investigator: Lindsey Knowles, PhD — University of Washington
- Study coordinator: Lindsey Knowles, PhD
- Email: lmknow@uw.edu
- Phone: 206-744-9640
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Treadmill-based virtual reality walking training for MS patients
This study tests whether a treadmill with virtual reality and smart socks can help people with multiple sclerosis walk better and feel safer in daily life.
-
Virtual Reality and Mental Practice to Improve Balance and Walking in Relapsing MS
This study tests whether virtual reality training or mental practice can improve balance and walking in people with relapsing–remitting multiple sclerosis.
-
REAL-MS: A Look at Autologous Stem Cell Transplant vs High-Efficacy MS Therapies in Real-World Care
This study tests how AHSCT compares to high-efficacy MS medicines in adults treated in routine clinical care.
-
Tolebrutinib in real-world MS care for patients treated by clinicians
This real-world study sees how tolebrutinib is used for multiple sclerosis patients and what outcomes look like in everyday practice.
-
Pilates via live video vs. prerecorded videos for people with multiple sclerosis
This study tests whether live, coach-led Pilates sessions through video calls are more beneficial than prerecorded Pilates videos for adults with MS.
-
Cooling During Inpatient Rehab for People with MS
This trial tests whether wearing a cooling vest during intensive training can reduce fatigue and improve walking, strength, balance, and cognition in people with multiple sclerosis during a 3-week inpatient rehab stay.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.